Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Nature Medicine

• Publication date

  2010-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/nm.2245PMID 21102461
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Emergent Cerebrovascular Disease Risk Factor Weighting: Is Transient Ischemic Attack an Imminent Threat?

  2009cited by this paper
• Mechanism of differential control of NMDA receptor activity by NR2 subunits

  2009cited by this paper
• Impairments in fear conditioning in mice lacking the nNOS gene.

  2009cited by this paper
• Abnormal social behavior, hyperactivity, impaired remote spatial memory, and increased D1-mediated dopaminergic signaling in neuronal nitric oxide synthase knockout mice

  2009cited by this paper
• Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications.

  2009cited by this paper
• Cell-free expression for nanolipoprotein particles: building a high-throughput membrane protein solubility platform.

  2009cited by this paper
• The cost of cerebral ischaemia.

  2008cited by this paper
• PDZ Protein Interactions Underlying NMDA Receptor-Mediated Excitotoxicity and Neuroprotection by PSD-95 Inhibitors

  2007cited by this paper
• Pathologically activated therapeutics for neuroprotection

  2007cited by this paper
• Pathologically activated therapeutics for neuroprotection

  2007cited by this paper
• Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond

  2006cited by this paper
• Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists.

  2006cited by this paper
• The PSD95–nNOS interface

  2005cited by this paper
• Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors

  2005cited by this paper
• Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury

  2004cited by this paper
• Synthesis of nitric oxide in post‐ganglionic myenteric neurons during endotoxemia: implications for gastric motor function

  2004cited by this paper
• Therapeutic N-methyl-D-aspartate receptor antagonists: will reality meet expectation?

  2003cited by this paper
• Bringing order to the glutamate chaos in schizophrenia.

  2003cited by this paper
• Selective Enrichment of Membrane Proteins by Partition Phase Separation for Proteomic Studies

  2003cited by this paper
• NMDA receptor pathways as drug targets

  2002cited by this paper
• Treatment of Ischemic Brain Damage by Perturbing NMDA Receptor- PSD-95 Protein Interactions

  2002cited by this paper
• Brain serotonin dysfunction accounts for aggression in male mice lacking neuronal nitric oxide synthase.

  2001cited by this paper
• Formation of nNOS/PSD-95 PDZ dimer requires a preformed beta-finger structure from the nNOS PDZ domain.

  2000cited by this paper
• Solution structure and backbone dynamics of the second PDZ domain of postsynaptic density-95.

  2000cited by this paper
• Altered Interaction Between PSD‐95 and the NMDA Receptor Following Transient Global Ischemia

  2000cited by this paper
• Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein.

  1999cited by this paper
• The changing landscape of ischaemic brain injury mechanisms

  1999cited by this paper
• Subcellular localization of the neuronal isoform of nitric oxide synthase in the rat brain: a critical evaluation.

  1998cited by this paper
• Emerging treatments for stroke in humans.

  1996cited by this paper
• Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains.

  1996cited by this paper
• Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice

  1996cited by this paper
• Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase

  1995cited by this paper
• Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase.

  1994cited by this paper
• Subcellular Localization and Characterization of Neuronal Nitric Oxide Synthase

  1994cited by this paper
• Reversible middle cerebral artery occlusion without craniectomy in rats.

  1989cited by this paper

• A modified tail suspension test for the assessment of behavioral despair in mice after stroke.

  2026cites this paper
• Therapeutic potential of nitric oxide and its donors in hemorrhagic and ischemic stroke: a systematic review.

  2026cites this paper
• Review of neuroprotective potential of natural products against hypoxia-induced neuronal injury.

  2026cites this paper
• GW201 mediates neuroprotection via allosteric modulation of NMDA receptor activity in the middle cerebral artery occlusion (MCAO) model.

  2026cites this paper
• S-nitrosylation of Dexras1 attenuates fear memory generalization in the infralimbic cortex.

  2026cites this paper
• Elevated circulation postsynaptic density protein 95 as a potential biomarker for predicting the diagnosis and prognosis of acute cerebral infarction

  2025cites this paper
• Development of cell-permeable and plasma-stable peptidomimetic inhibitors against PSD-95/nNOS interaction as potential anti-ischemic stroke agents.

  2025cites this paper
• Loberamisal injection for the treatment of acute ischaemic stroke: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial

  2025cites this paper
• Advances in cerebral edema research and targeted drug delivery systems.

  2025cites this paper
• K739 is preferentially targeted over K725 in the deSUMOylation process of neuronal nitric oxide synthase

  2025cites this paper
• Ischemic stroke and intervention strategies based on the timeline of stroke progression: Review and prospects

  2025cites this paper
• Synaptic scaffold protein PSD-95: a therapeutic target for Alzheimer's disease.

  2025cites this paper
• Nanomedicine for Treating Major Brain Diseases: Advances and Future Directions.

  2025cites this paper
• Multifaceted Role of RIMBP2 in Promoting Hearing in Murine Cochlear Hair Cells

  2025cites this paper
• Uncoupling toxic NO signaling: Progress, challenges, and therapeutic promise of disrupting the PSD-95/nNOS protein-protein interaction.

  2025cites this paper
• Loberamisal for Acute Ischaemic Stroke (LAIS): a multicentre, randomised, double-blind, parallel, placebo-controlled phase III clinical trial

  2025cites this paper
• Soluble TREM2 ameliorates pathological phenotypes in ischemic stroke models via modulating neuronal and microglial functions

  2025influential citation
• Enduring Effects of Humanin on Mitochondrial Systems in TBI Pathology

  2025cites this paper
• Endothelial GATAD1 Exacerbates Blood-brain Barrier Dysfunction in Ischemic Stroke through Caveolae-mediated Transcytosis

  2025cites this paper
• Unveiling the role of PSD95 phosphorylation after traumatic brain injury: insights from phosphoproteomic analysis

  2025cites this paper
• A Molecular Recruitment Colocalization Platform for Visualizing Multi‐Protein Interactions and Engineering Biomolecular Condensates in Living Cells

  2025cites this paper
• Redox modulation of the complement cascade contributes to synapse loss in Alzheimer's disease

  2025cites this paper
• Tissue geometry spatiotemporally drives bacterial infections.

  2025cites this paper
• Effects of Different SSRIs on nNOS mRNA Expression in the Hippocampus and Prefrontal Cortex of Chronically Stressed Rats

  2025cites this paper
• FOXO3a-BAP1 axis regulates neuronal ferroptosis in early brain injury after subarachnoid hemorrhage

  2025influential citation
• Semaglultide targets Spp1+ microglia/macrophage to attenuate neuroinflammation following perioperative stroke

  2025cites this paper
• Intracalvariosseous injection: an approach for central nervous system drug delivery through skull bone marrow with a preclinical research in stroke

  2025cites this paper
• Astrocytic BEST1 can serve as a target for functional recovery after ischemic stroke.

  2025cites this paper
• Metabolite classification through novel metabolomics framework reveals mechanism underlying the therapeutic effects of PSD95-nNOS blockade for post-stroke depression

  2025cites this paper
• G6PD protects against cerebral ischemia-reperfusion injury by inhibiting excessive mitophagy.

  2025cites this paper
• Nos1+ neurons are critical for motor learning and post-stroke motor recovery.

  2025cites this paper
• Targeting Atf4 for enhanced neuroprotection: Role of quercetin-loaded EVs in ischemic stroke

  2025cites this paper
• Anti-neuroinflammatory agent rhein lysinate-based self-assembled injectable hydrogel loaded with ZL006 for promoting post-stroke functional recovery.

  2025cites this paper
• Exploring NMDAR pathways in ischemic stroke: implications for neurotoxic and neuroprotective mechanisms and therapeutic strategies

  2025cites this paper
• Novel Hypochlorous Acid-Activated Near-Infrared Probe Monitors the Dynamic Changes of Myeloperoxidase Activity in Ischemic Brain.

  2025cites this paper
• Efficacy and safety of Y-3 intracalvariosseous injection versus intravenous injection in the treatment of acute large hemispheric infarction (SOLUTION-2): rationale and design of a multicentre, prospective, randomised, open-label, blind endpoint (PROBE) trial

  2025cites this paper
• One-stone-four-birds strategy to construct magnetic mesoporous nano-ratio fluorescence sensor for efficient discovery of PSD95-nNOS uncouplers

  2025cites this paper
• Mitochondrial Cardiolipin-Targeted Tetrapeptide, SS-31, Exerts Neuroprotective Effects Within In Vitro and In Vivo Models of Spinal Cord Injury

  2025cites this paper
• The IC87201 (a PSD95/nNOS Inhibitor) Attenuates Post- Stroke Injuries

  2024cites this paper
• Pathogenetic scenarios of the development of brain ischemia and the main elements of the ischemic cascade

  2024cites this paper
• Effects of Methionine Deficiency on Nutrient Composition, No, Nos Activity and Mrna Expression in Nf-κb Signal Pathway of the Liver and Kidney in Broiler

  2024cites this paper
• Deciphering the dual role of N-methyl-D-Aspartate receptor in postoperative cognitive dysfunction: A comprehensive review.

  2024cites this paper
• The case for neuregulin-1 as a clinical treatment for stroke

  2024cites this paper
• Inhibition of Anaplastic Lymphoma Kinase Protects From Ischemic Stroke

  2024cites this paper
• HDAC9 Deficiency Upregulates cGMP-dependent Kinase II to Mitigate Neuronal Apoptosis in Ischemic Stroke

  2024cites this paper
• Combinatorial therapy with sub-effective Ro25-6981 and ZL006 ameliorates depressive-like behavior in single or combined stressed male mice.

  2024cites this paper
• The regulatory role of the Netrin-1/UNC5H3 pathway in neuronal pyroptosis after stroke.

  2024cites this paper
• Enhanced Fyn-tau and NR2B-PSD95 interactions in epileptic foci in experimental models and human epilepsy

  2024cites this paper
• Maternal nicotine exposure promotes hippocampal CeRNA-mediated excitotoxicity and social barriers in adolescent offspring mice.

  2024cites this paper
• Post-stroke effects of IC87201 on neurobehavioral function and brain injuries: A stereological study

  2024influential citation
• The Role of PDZ in Cerebral Ischemia

  2024cites this paper
• Nanotechnology approaches to drug delivery for the treatment of ischemic stroke

  2024cites this paper
• Disrupting stroke-induced GAT-1-syntaxin1A interaction promotes functional recovery after stroke

  2024cites this paper
• PSD-95 Protein: A Promising Therapeutic Target in Chronic Pain

  2024cites this paper
• Dynamic changes in Beclin-1, LC3B, and p62 in aldose reductase-knockout mice at different time points after ischemic stroke

  2024cites this paper
• Advancements in Ischemic Stroke Management: Transition from Traditional to Nanotechnological Approaches

  2024cites this paper
• The neuroprotective effects of normobaric oxygen therapy after stroke

  2024cites this paper
• Advancements in the Research of New Modulators of Nitric Oxide Synthases Activity

  2024cites this paper
• Sulbactam protects neurons against double neurotoxicity of amyloid beta and glutamate load by upregulating glial glutamate transporter 1

  2024cites this paper
• Polarized benzene rings can promote the interaction between CaM and the CaMBD region of nNOS

  2024cites this paper
• Reduction of Oxidative Stress and Excitotoxicity by Mesenchymal Stem Cell Biomimetic Co-Delivery System for Cerebral Ischemia-Reperfusion Injury Treatment.

  2024cites this paper
• Molecular Targeting of Ischemic Stroke: The Promise of Naïve and Engineered Extracellular Vesicles

  2024cites this paper
• Glutamate-releasing BEST1 channel is a new target for neuroprotection against ischemic stroke with wide time window

  2023cites this paper
• The Physiological Function of nNOS-Associated CAPON Proteins and the Roles of CAPON in Diseases

  2023cites this paper
• GluN2B-containing NMDARs in the mammalian brain: pharmacology, physiology, and pathology

  2023cites this paper
• Advances in nitric oxide regulators for the treatment of ischemic stroke.

  2023cites this paper
• nNOS and Neurological, Neuropsychiatric Disorders: A 20-Year Story

  2023influential citation
• The α2δ-1-NMDA receptor complex and its potential as a therapeutic target for ischemic stroke

  2023influential citation
• Cerebral organoids transplantation repairs infarcted cortex and restores impaired function after stroke

  2023cites this paper
• Preclinical evaluation of ZL006-05, a new antistroke drug with fast-onset antidepressant and anxiolytic effects

  2023cites this paper
• Discovery of benzyloxy benzamide derivatives as potent neuroprotective agents against ischemic stroke.

  2023cites this paper
• CXCR4-BTK axis mediate pyroptosis and lipid peroxidation in early brain injury after subarachnoid hemorrhage via NLRP3 inflammasome and NF-κB pathway

  2023influential citation
• Surfeit Locus Protein 4 as a Novel Target for Therapeutic Intervention in Cerebral Ischemia–Reperfusion Injury

  2023influential citation
• High-frequency repetitive transcranial magnetic stimulation promotes neural stem cell proliferation after ischemic stroke

  2023cites this paper
• The role of N-methyl-D-aspartate glutamate receptors in Alzheimer's disease: from pathophysiology to therapeutic approaches.

  2023cites this paper
• Progesterone improved the behavior of PC12 cells under OGD/R by reducing FABP5 expression and inhibiting TLR4/NF-κB signaling pathway

  2023cites this paper
• Signaling pathways in brain ischemia: Mechanisms and therapeutic implications.

  2023cites this paper
• Neuronal Nitric Oxide Synthase and Post-Translational Modifications in the Development of Central Nervous System Diseases: Implications and Regulation

  2023influential citation
• Effect of electrode configuration in electroacupuncture on ischemic stroke treatment in rats

  2023cites this paper
• Favorable neuroprotective effect of intra-arterial application of edaravone dexborneol in ischemic stroke rats.

  2023cites this paper
• Drugs/agents for the treatment of ischemic stroke: Advances and perspectives

  2023cites this paper
• COVID-19-induced neurological symptoms: focus on the role of metal ions

  2023cites this paper
• Lithium Co-administration with rutin improves post-stroke neurological outcomes via suppressing Gsk-3β activity in a rat model.

  2023cites this paper
• Downregulation of Preso protects against ischemic/reperfusion-mediated neuronal injury through regulating PSD95-nNOS/YAP pathways.

  2023cites this paper
• Surface-Tailored Nanoplatform for the Diagnosis and Management of Stroke: Current Strategies and Future Outlook

  2023cites this paper
• Recent advances in the study of anesthesia-and analgesia-related mechanisms of S-ketamine

  2023cites this paper
• IC87201, a PSD-95/nNOS Inhibitor, Ameliorates Heart Rate Variability in the Rat Model of Middle Cerebral Artery Occlusion

  2023cites this paper
• ACSL4-Mediated Ferroptosis and Its Potential Role in Central Nervous System Diseases and Injuries

  2023influential citation
• Upregulation of HDAC9 in hippocampal neurons mediates depression-like behaviours by inhibiting ANXA2 degradation

  2023cites this paper
• Synaptotagmin-3 interactions with GluA2 mediate brain damage and impair functional recovery in stroke.

  2023cites this paper
• Reperfusion and cytoprotective agents are a mutually beneficial pair in ischaemic stroke therapy: an overview of pathophysiology, pharmacological targets and candidate drugs focusing on excitotoxicity and free radical

  2023cites this paper
• Multifaceted role of RIMBP2 in promoting hearing in murine cochlear hair cells

  2022cites this paper
• Glutamate excitotoxicity: Potential therapeutic target for ischemic stroke.

  2022cites this paper
• Roles of Nitric Oxide in Brain Ischemia and Reperfusion

  2022cites this paper
• Advances of nano drug delivery system for the theranostics of ischemic stroke

  2022cites this paper
• Exploration in the Therapeutic and Multi-Target Mechanism of Ketamine on Cerebral Ischemia Based on Network Pharmacology and Molecular Docking

  2022cites this paper
• Cross-talk between GABAergic postsynapse and microglia regulate synapse loss after brain ischemia

  2022cites this paper
• An Injectable Hydrogel for Treatment of Chronic Neuropathic Pain.

  2022cites this paper
• Inhibition of the NR2B-PSD95 interaction exerts neuroprotective effects on retinal ischemia-reperfusion injury.

  2022cites this paper
• Identification and Optimization of Novel Small-Molecule Cas9 Inhibitors by Cell-Based High-Throughput Screening.

  2022cites this paper